3716 — Cenra Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual income statement for Cenra, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,181	7,949	8,457	8,575	8,919
Cost of Revenue
Gross Profit	2,969	2,865	3,088	3,140	3,407
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	7,760	7,525	8,077	8,344	8,620
Operating Profit	421	424	379	231	299
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	658	659	589	391	386
Provision for Income Taxes
Net Income After Taxes	560	516	479	324	319
Minority Interest
Net Income Before Extraordinary Items
Net Income	557	518	478	322	317
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	557	518	478	322	317
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.85	1.72	1.59	1.07	2.48
Dividends per Share